Want to join the conversation?
$HBAN 2Q15 PR: FY15 Outlook: Commitment to positive operating leverage, excluding Significant Items & net MSR activity is both inclusive & exclusive of the impact of HTF. We continue to expect noninterest expense growth of 2-4%, excluding Significant Items & recurring expense related to HTF. Effective tax rate expected to be in the range of 24-27%
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.